The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
15+ Premium newsletters by leading experts。关于这个话题，PDF资料提供了深入分析
李锡铭同志的一生，是革命的一生、战斗的一生、光辉的一生，是为党和人民事业鞠躬尽瘁的一生。他的革命精神和高尚品德永远值得我们学习。，推荐阅读体育直播获取更多信息
Фото: Isabel Infantes / Reuters
比爾·蓋茨據報承認與兩俄羅斯女性有染並道歉 梅琳達稱想起「令人痛苦的時光」